The AuguroSubscribe
Section

Health

Medicine, the body, and public health

GLP-1 Drugs Are Reducing Addiction, Anxiety, and Depression — The Metabolic-Mental Health Link Is Real
Lead Story

GLP-1 Drugs Are Reducing Addiction, Anxiety, and Depression — The Metabolic-Mental Health Link Is Real

Clinical data and observational studies from 2025 show measurable reductions in addiction behavior, anxiety symptoms, and depression markers among GLP-1 users — effects that were not the drugs' design target. The mechanism may be the most important finding in psychiatry in a generation.

Dr. Amara SinghMarch 18, 2026
The Longevity Industry's First Credible Signal
Health

The Longevity Industry's First Credible Signal

For the first time, clinical interventions targeting biological aging have produced statistically significant human results — and the timeline for market availability has compressed in ways the longevity field has not yet fully communicated.

Dr. Priya Nair8 min
The Psychiatry We Lost
Health

The Psychiatry We Lost

For thirty years, psychiatry bet everything on the biological model of mental illness. The drugs worked, sort of, for some people. What got lost was everything else — and now a generation is paying the price.

Nadia Osei14 min
Why American Drugs Cost More Than Everywhere Else
Health

Why American Drugs Cost More Than Everywhere Else

The United States pays two to three times what other wealthy countries pay for the same medications. This is a policy choice, not an economic law — and the politics of changing it are more complicated than either party admits.

Dr. Amara Singh12 min
What We Eat Is Killing Us. The Signal Was There All Along.
Health

What We Eat Is Killing Us. The Signal Was There All Along.

Metabolic disease — obesity, type 2 diabetes, cardiovascular disease, fatty liver — now accounts for the majority of US healthcare spending. The dietary signals that predicted this have been visible for decades.

Dr. Amara Singh13 min